HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arinaga, M. Articles by Mitsudomi, T. Search for Related Content PubMed PubMed Citation Articles by Arinaga, M. Articles by Mitsudomi, T. Related Collections Related Article

Ann Thorac Surg 2000;70:401-405
© 2000 The Society of Thoracic Surgeons

---

Original articles: general thoracic

Expression of human telomerase subunit genes in primary lung cancer and its clinical significance

^a Department of Department of Thoracic Surgery Aichi Cancer Center Hospital, , Aichi Cancer Center Research Institute, Aichi Cancer Center, Nagoya, Japan
^b Department of Ultrastructure Research, Aichi Cancer Center Research Institute, Aichi Cancer Center, Nagoya, Japan

Address reprint requests to Dr Mitsudomi, Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan
e-mail: mitsudom{at}leo.bekkoame.ne.jp

Background. Three major components of human telomerase, RNA component (hTERC), telomerase-associated protein (TEP1), and catalytic subunit (hTERT) have been cloned recently. The aim of this study was to examine the expression of these genes and to search for clinical usefulness.

Methods. Expression of these genes was evaluated by reverse transcription-polymerase chain reaction in 92 human lung cancers and in 32 non-neoplastic lung tissues. In 15 patients, both telomerase activity by telomeric repeat amplification protocol assay and expression were evaluated.

Results. hTERT expression was best associated with telomerase activity with a concordance of 77%. In 92 lung cancer tissues, hTERC, TEP1, and hTERT were expressed in 100%, 93%, and 89%, respectively. Whereas most adjacent non-neoplastic lung tissues expressed hTERC and TEP1 (94% and 100%, respectively), hTERT was detected in only 1 of 32 normal lungs. However, there was no relationship between hTERT expression and clinicopathologic features.

Conclusions. hTERT expression can be a surrogate for telomerase activity that may serve as a novel biomarker of lung cancer with high specificity and sensitivity.

Related Article

Invited commentary

David H. Harpole, Jr
Ann. Thorac. Surg. 2000 70: 405-406. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				R. METZGER, D. VALLBOHMER, C. MULLER-TIDOW, H. HIGASHI, E. BOLLSCHWEILER, U. WARNECKE-EBERZ, J. BRABENDER, S. E. BALDUS, H. XI, W. E. BERDEL, et al. Increased Human Telomerase Reverse Transcriptase (hTERT) mRNA Expression but not Telomerase Activity is Related to Survival in Curatively Resected Non-small Cell Lung Cancer Anticancer Res, April 1, 2009; 29(4): 1157 - 1162. [Abstract] [Full Text] [PDF]

				K M Fong, Y Sekido, A F Gazdar, and J D Minna Lung cancer * 9: Molecular biology of lung cancer: clinical implications Thorax, October 1, 2003; 58(10): 892 - 900. [Abstract] [Full Text] [PDF]

				E. Dikmen, M. Kara, G. Dikmen, H. Cakmak, and P. Dogan Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 194 - 199. [Abstract] [Full Text] [PDF]

				L. Wang, J.-C. Soria, B. L. Kemp, D. D. Liu, L. Mao, and F. R. Khuri hTERT Expression Is a Prognostic Factor of Survival in Patients with Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., September 1, 2002; 8(9): 2883 - 2889. [Abstract] [Full Text] [PDF]